{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T11:03:19Z","timestamp":1789729399663,"version":"4.0.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Japan Society for the Promotion of ScienceJapan Society for the Promotion of Science (JSPS)","award":["16K11493"],"award-info":[{"award-number":["16K11493"]}]},{"name":"Japan Society for the Promotion of ScienceJapan Society for the Promotion of Science (JSPS)","award":["16H05508"],"award-info":[{"award-number":["16H05508"]}]},{"name":"Japan Society for the Promotion of ScienceJapan Society for the Promotion of Science (JSPS)","award":["16H05144"],"award-info":[{"award-number":["16H05144"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.jsbmb.2017.11.005","type":"journal-article","created":{"date-parts":[[2017,11,14]],"date-time":"2017-11-14T11:02:53Z","timestamp":1510657373000},"page":"70-76","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"special_numbering":"C","title":["Mechanisms involved in bone resorption regulated by vitamin D"],"prefix":"10.1016","volume":"177","author":[{"given":"Yuko","family":"Nakamichi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Udagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuo","family":"Suda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoyuki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsbmb.2017.11.005_bib0005","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/bonekey.2013.215","article-title":"Coupling the activities of bone formation and resorption: a multitude of signals within the basic multicellular unit","volume":"3","author":"Sims","year":"2014","journal-title":"Bonekey. Rep."},{"issue":"3","key":"10.1016\/j.jsbmb.2017.11.005_bib0010","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.devcel.2014.03.013","article-title":"Osterix marks distinct waves of primitive and definitive stromal progenitors during bone marrow development","volume":"29","author":"Mizoguchi","year":"2014","journal-title":"Dev. Cell"},{"issue":"2","key":"10.1016\/j.jsbmb.2017.11.005_bib0015","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.stem.2014.06.008","article-title":"Leptin-receptor-expressing mesenchymal stromal cells represent the main source of bone formed by adult bone marrow","volume":"15","author":"Zhou","year":"2014","journal-title":"Cell Stem Cell"},{"issue":"5","key":"10.1016\/j.jsbmb.2017.11.005_bib0020","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1210\/er.2012-1026","article-title":"The osteocyte: an endocrine cell \u2026 and more","volume":"34","author":"Dallas","year":"2013","journal-title":"Endocr. Rev."},{"issue":"18","key":"10.1016\/j.jsbmb.2017.11.005_bib0025","doi-asserted-by":"crossref","first-page":"7260","DOI":"10.1073\/pnas.87.18.7260","article-title":"Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells","volume":"87","author":"Udagawa","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.jsbmb.2017.11.005_bib0030","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1083\/jcb.200806139","article-title":"Identification of cell cycle-arrested quiescent osteoclast precursors in vivo","volume":"184","author":"Mizoguchi","year":"2009","journal-title":"J. Cell Biol."},{"issue":"3","key":"10.1016\/j.jsbmb.2017.11.005_bib0035","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1210\/edrv.20.3.0367","article-title":"Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families","volume":"20","author":"Suda","year":"1999","journal-title":"Endocr. Rev."},{"issue":"6937","key":"10.1016\/j.jsbmb.2017.11.005_bib0040","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.jsbmb.2017.11.005_bib0045","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1056\/NEJM199202063260601","article-title":"Treatment of postmenopausal osteoporosis with calcitriol or calcium","volume":"326","author":"Tilyard","year":"1992","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.jsbmb.2017.11.005_bib0050","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/BF00305521","article-title":"Effects of 1 alpha-hydroxyvitamin D3 on lumbar bone mineral density and vertebral fractures in patients with postmenopausal osteoporosis","volume":"54","author":"Orimo","year":"1994","journal-title":"Calcif. Tissue Int."},{"issue":"4","key":"10.1016\/j.jsbmb.2017.11.005_bib0055","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.bone.2011.07.011","article-title":"A new active vitamin D3 analog, eldecalcitol, prevents the risk of osteoporotic fractures-a randomized, active comparator, double-blind study","volume":"49","author":"Matsumoto","year":"2011","journal-title":"Bone"},{"issue":"6","key":"10.1016\/j.jsbmb.2017.11.005_bib0060","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1517\/14656566.2013.778825","article-title":"Eldecalcitol: newly developed active vitamin D3 analog for the treatment of osteoporosis","volume":"14","author":"Hagino","year":"2013","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.jsbmb.2017.11.005_bib0065","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/bonekey.2014.8","article-title":"Vitamin D analogs and bone: preclinical and clinical studies with eldecalcitol","volume":"3","author":"Matsumoto","year":"2014","journal-title":"Bonekey. Rep."},{"issue":"2 Pt 1","key":"10.1016\/j.jsbmb.2017.11.005_bib0070","first-page":"E234","article-title":"Effects of serum calcium and phosphorus on skeletal mineralization in vitamin D-deficient rats","volume":"251","author":"Holtrop","year":"1986","journal-title":"Am. J. Physiol."},{"issue":"11","key":"10.1016\/j.jsbmb.2017.11.005_bib0075","doi-asserted-by":"crossref","first-page":"4982","DOI":"10.1210\/endo.140.11.7110","article-title":"Rescue of the skeletal phenotype of vitamin D receptor-ablated mice in the setting of normal mineral ion homeostasis: formal histomorphometric and biomechanical analyses","volume":"140","author":"Amling","year":"1999","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.jsbmb.2017.11.005_bib0080","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1002\/jbmr.3096","article-title":"VDR in osteoblast-lineage cells primarily mediates vitamin D treatment-induced increase in bone mass by suppressing bone resorption","volume":"32","author":"Nakamichi","year":"2017","journal-title":"J. Bone Miner. Res."},{"issue":"2","key":"10.1016\/j.jsbmb.2017.11.005_bib0085","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1172\/JCI24742","article-title":"c-Fos protein as a target of anti-osteoclastogenic action of vitamin D, and synthesis of new analogs","volume":"116","author":"Takasu","year":"2006","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.jsbmb.2017.11.005_bib0090","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00774-009-0084-4","article-title":"1\u03b1,25-dihydroxy vitamin D3 inhibits osteoclastogenesis through IFN-beta-dependent NFATc1 suppression","volume":"27","author":"Sakai","year":"2009","journal-title":"J. Bone Miner. Metab."},{"issue":"11","key":"10.1016\/j.jsbmb.2017.11.005_bib0095","doi-asserted-by":"crossref","first-page":"e111845","DOI":"10.1371\/journal.pone.0111845","article-title":"The vitamin D analogue ED71 but not 1, 25(OH)2D3 targets HIF1\u03b1 protein in osteoclasts","volume":"9","author":"Sato","year":"2014","journal-title":"PLoS. One"},{"key":"10.1016\/j.jsbmb.2017.11.005_bib0100","doi-asserted-by":"crossref","first-page":"16030","DOI":"10.1038\/boneres.2016.30","article-title":"Vitamin D receptor expression in human bone tissue and dose-dependent activation in resorbing osteoclasts","volume":"4","author":"Zarei","year":"2016","journal-title":"Bone. Res."},{"issue":"12","key":"10.1016\/j.jsbmb.2017.11.005_bib0105","doi-asserted-by":"crossref","first-page":"5332","DOI":"10.1210\/endo.142.12.8544","article-title":"Aberrant growth plate development in VDR\/RXR gamma double null mutant mice","volume":"142","author":"Yagishita","year":"2001","journal-title":"Endocrinology"},{"issue":"10","key":"10.1016\/j.jsbmb.2017.11.005_bib0110","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1210\/en.2010-0354","article-title":"The receptor-dependent actions of 1,25-dihydroxyvitamin D are required for normal growth plate maturation in NPt2a knockout mice","volume":"151","author":"Miedlich","year":"2010","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.jsbmb.2017.11.005_bib0115","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/jbmr.2081","article-title":"Identification of the vitamin D receptor in osteoblasts and chondrocytes but not osteoclasts in mouse bone","volume":"29","author":"Wang","year":"2014","journal-title":"J. Bone Miner. Res."},{"issue":"4","key":"10.1016\/j.jsbmb.2017.11.005_bib0120","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/ng0897-391","article-title":"Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning","volume":"16","author":"Yoshizawa","year":"1997","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.jsbmb.2017.11.005_bib0125","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1053\/j.gastro.2008.12.051","article-title":"Intestinal vitamin D receptor is required for normal calcium and bone metabolism in mice","volume":"136","author":"Xue","year":"2009","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.jsbmb.2017.11.005_bib0130","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1210\/en.2012-1542","article-title":"Vitamin D receptor in osteoblasts is a negative regulator of bone mass control","volume":"154","author":"Yamamoto","year":"2013","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.jsbmb.2017.11.005_bib0135","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1172\/JCI45890","article-title":"Normocalcemia is maintained in mice under conditions of calcium malabsorption by vitamin D-induced inhibition of bone mineralization","volume":"122","author":"Lieben","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"16","key":"10.1016\/j.jsbmb.2017.11.005_bib0140","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1242\/dev.02480","article-title":"Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors","volume":"133","author":"Rodda","year":"2006","journal-title":"Development"},{"issue":"5","key":"10.1016\/j.jsbmb.2017.11.005_bib0145","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.cell.2007.07.025","article-title":"Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts","volume":"130","author":"Nakamura","year":"2007","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.jsbmb.2017.11.005_bib0150","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1210\/endo-123-5-2600","article-title":"Osteoblastic cells are involved in osteoclast formation","volume":"123","author":"Takahashi","year":"1988","journal-title":"Endocrinology"},{"issue":"6274","key":"10.1016\/j.jsbmb.2017.11.005_bib0155","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/345442a0","article-title":"The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene","volume":"345","author":"Yoshida","year":"1990","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.jsbmb.2017.11.005_bib0160","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","article-title":"Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL","volume":"95","author":"Yasuda","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.jsbmb.2017.11.005_bib0165","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.jsbmb.2017.11.005_bib0170","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1182\/blood.V99.1.111","article-title":"Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects","volume":"99","author":"Dai","year":"2002","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jsbmb.2017.11.005_bib0175","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1073\/pnas.97.4.1566","article-title":"RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism","volume":"97","author":"Li","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.jsbmb.2017.11.005_bib0180","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","article-title":"Osteoprotegerin: a novel secreted protein involved in the regulation of bone density","volume":"89","author":"Simonet","year":"1997","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.jsbmb.2017.11.005_bib0185","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1210\/endo.139.3.5837","article-title":"Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG\/OCIF inhibits osteoclastogenesis in vitro","volume":"139","author":"Yasuda","year":"1998","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.jsbmb.2017.11.005_bib0190","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1210\/endo.140.2.6673","article-title":"Stimulation of osteoclast formation by 1,25-dihydroxyvitamin D requires its binding to vitamin D receptor (VDR) in osteoblastic cells: studies using VDR knockout mice","volume":"140","author":"Takeda","year":"1999","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.jsbmb.2017.11.005_bib0195","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.bone.2006.09.007","article-title":"N. Udagawa New 19-nor-(20S)-1alpha, 25-dihydroxyvitamin D3 analogs strongly stimulate osteoclast formation both in vivo and in vitro","volume":"40","author":"Sato","year":"2007","journal-title":"Bone"},{"issue":"11","key":"10.1016\/j.jsbmb.2017.11.005_bib0200","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1359\/jbmr.070716","article-title":"Relative value of 25(OH)D and 1,25(OH)2D measurements","volume":"22","author":"Lips","year":"2007","journal-title":"J. Bone Miner. Res."},{"issue":"2","key":"10.1016\/j.jsbmb.2017.11.005_bib0205","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1042\/cs0990133","article-title":"Induction of osteoclasts from CD14-positive human peripheral blood mononuclear cells by receptor activator of nuclear factor kappaB ligand (RANKL)","volume":"99","author":"Nicholson","year":"2000","journal-title":"Clin. Sci. (Lond.)"},{"issue":"5184","key":"10.1016\/j.jsbmb.2017.11.005_bib0210","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1126\/science.7939685","article-title":"c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling","volume":"266","author":"Grigoriadis","year":"1994","journal-title":"Science"},{"issue":"41","key":"10.1016\/j.jsbmb.2017.11.005_bib0215","doi-asserted-by":"crossref","first-page":"16568","DOI":"10.1073\/pnas.1308755110","article-title":"HIF1\u03b1 is required for osteoclast activation by estrogen deficiency in postmenopausal osteoporosis","volume":"110","author":"Miyauchi","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"25","key":"10.1016\/j.jsbmb.2017.11.005_bib0220","doi-asserted-by":"crossref","first-page":"10006","DOI":"10.1073\/pnas.1207361109","article-title":"Spleen serves as a reservoir of osteoclast precursors through vitamin D-induced IL-34 expression in osteopetrotic op\/op mice","volume":"109","author":"Nakamichi","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"Suppl. 1","key":"10.1016\/j.jsbmb.2017.11.005_bib0225","first-page":"S20","article-title":"Absence of the VDR in osteoclasts results in increased bone resorption and osteoclast survival","volume":"31","author":"Starczak","year":"2016","journal-title":"J. Bone Miner. Res."},{"issue":"7","key":"10.1016\/j.jsbmb.2017.11.005_bib0230","doi-asserted-by":"crossref","first-page":"e42005","DOI":"10.1371\/journal.pone.0042005","article-title":"Cathepsin K-Cre causes unexpected germline deletion of genes in mice","volume":"7","author":"Winkeler","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jsbmb.2017.11.005_bib0235","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/jbmr.555","article-title":"Daily administration of eldecalcitol (ED-71), an active vitamin D analog, increases bone mineral density by suppressing RANKL expression in mouse trabecular bone","volume":"27","author":"Harada","year":"2012","journal-title":"J. Bone Miner. Res."},{"issue":"4","key":"10.1016\/j.jsbmb.2017.11.005_bib0240","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S8756-3282(02)00682-8","article-title":"ED-71, a vitamin D analog, is a more potent inhibitor of bone resorption than alfacalcidol in an estrogen-deficient rat model of osteoporosis","volume":"30","author":"Uchiyama","year":"2002","journal-title":"Bone"},{"issue":"17","key":"10.1016\/j.jsbmb.2017.11.005_bib0245","doi-asserted-by":"crossref","first-page":"7009","DOI":"10.1073\/pnas.1218799110","article-title":"Sphingosine-1-phosphate-mediated osteoclast precursor monocyte migration is a critical point of control in antibone-resorptive action of active vitamin D","volume":"110","author":"Kikuta","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7237","key":"10.1016\/j.jsbmb.2017.11.005_bib0250","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nature07713","article-title":"Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis","volume":"458","author":"Ishii","year":"2009","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.jsbmb.2017.11.005_bib0255","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1002\/jbmr.490","article-title":"Lineage-committed osteoclast precursors circulate in blood and settle down into bone","volume":"26","author":"Muto","year":"2011","journal-title":"J. Bone Miner. Res."}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076017303345?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076017303345?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T23:56:04Z","timestamp":1760745364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076017303345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":51,"alternative-id":["S0960076017303345"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2017.11.005","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanisms involved in bone resorption regulated by vitamin D","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2017.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}